Plans by Asian tycoon Li Ka-shing to list his AS Watson health and beauty chain are set to be axed, with Singapore’s Temasek instead poised to invest up to US$6bn for a 25 per cent stake in the business, two people familiar with the matter said.
两位知情人士表示，屈臣氏(AS Watson)将终止其上市计划，因为新加坡的淡马锡(Temasek)准备投资总计60亿美元购买前者25%的股份。屈臣氏是亚洲大亨李嘉诚旗下的健康与美容连锁店。
您已阅读24%（340字），剩余76%（1080字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。